Pharmacy chain and benefits manager CVS Health Corp on Wednesday said as of Jan. 1 it will offer a new prescription benefit option guaranteeing its health plan clients 100 percent of any rebates, discounts or other fees paid by drugmakers.
SAN DIEGO Amgen Inc, updating the first trial of its bispecific antibody for multiple myeloma, said on Monday seven out of 10 patients given the second-highest dose of AMG420 responded to the drug, including four with no detectable cancer.
SAN DIEGO Dec 3 Amgen Inc, updating the
first trial of its bispecific antibody for multiple myeloma, on
Monday said seven out of ten patients given the second-highest
dose of AMG420 responded to the drug, including four with no
(This December 2 story corrects spelling in paragraph 5 to Alvarnas from Alvarnaz)
SAN DIEGO, Dec 2 Nearly 40 percent of lymphoma
patients treated with a single infusion of Gilead Sciences Inc's
Yescarta continued to respond to the cell therapy after
at least two years of follow up, the company said on Sunday.
A Loxo Oncology Inc drug shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation has won U.S. approval, the Food and Drug Administration announced on Monday.
Express Scripts Holding Co on Tuesday announced a new drug reimbursement list with lower U.S. prices for brand-name medications, as a way to encourage drugmakers to move away from paying rebates after a prescription is filled. The manager of prescription drug benefits for large corporate employers and government health plans said its new National Preferred Flex Formulary will be available as of Jan. 1 to all clients.
Updated U.S. guidelines on heart health advise more personalized assessment of risk as well as two newer types of cholesterol-lowering drugs for people at particularly high risk of heart attack or stroke.